Reducing Total Cost of Ownership

It's a tough question that every pharmaceutical company faces - how do you ensure quality and reliability of a drug product while reducing costs? The answer: Reduce your total cost of ownership.

Issues like breakage and delamination can result in costly recalls. By selecting the proper containment and delivery systems for your drug products early in the development process, you may be able to avoid these issues.

Through early partnerships, West can help manage the cost of ownership through:

  • Lifecycle management
  • Integrated containment and delivery
  • Regulatory and technical expertise

Read the following Case Studies to see how West can help:

NovaPure Case Study
Click Here
Daikyo Crystal Zenith®   sOLUTIONS   
Daikyo Crystal Zenith with the Ready Pack System
Solving the Challenge of High pH Injectable Drug Products                                                                                
Click Here
Daikyo Crystal Zenith® Components
Ready pack System

Solving Breakage for High-Volume Delivery

Click Here

Daikyo Crystal Zenith® Solutions
Daikyo Crystal Zenith Container Solutions

Avoid Delamination in Reconstituted Drug Products

Click Here
Envision™ Verification
Minimizing Drug Shortages of Life Promoting Medicine
Click Here

Envision™ Verification
Stoppers and Plungers
Mitigating the risk of a drug recall

Click Here
NovaPure® Components     
NovaPure Components
Partnering to Ensure High Quality & Optimized Functional Performance Based on Quality by Design (QbD)
Click Here





Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd.

NovaPure®, AccelTRA are registered trademarks or trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.